p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer
暂无分享,去创建一个
I. Runnebaum | M. Dürst | H. Diebolder | S. Weiss | M. Frey | N. Häfner | K. Nicolaus | M. Rengsberger